| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | US20040180337 Human extracellular signal regulated kinases |
| 09/16/2004 | US20040180328 Methods for rapid detection and identification of bioagents for environmental and product testing |
| 09/16/2004 | US20040180053 Binding protein |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180046 Bispecific molecules and uses thereof |
| 09/16/2004 | CA2517857A1 Methods for preventing gluconoylation of proteins |
| 09/16/2004 | CA2517287A1 Regulation of t cells by lag-3 (cd223) |
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/16/2004 | CA2516677A1 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/15/2004 | EP1457558A1 WEED CONTROLLER METABOLISM PROTEINS, GENES THEREOF AND USE OF THE SAME |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456398A2 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna and use of recombinant hpivi in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 09/15/2004 | EP1456386A2 Polycistronic expression of antibodies |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456382A2 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456373A2 Seminal vesicle tissue-specific promoters and uses thereof |
| 09/15/2004 | EP1456369A1 Polypeptides having protease activity and nucleic acids encoding same |
| 09/15/2004 | EP1456367A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
| 09/15/2004 | EP1456366A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456361A2 Process for harvesting crystalline particles from fermentation broth |
| 09/15/2004 | EP1456360A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456228A2 Method of isolation and purification of trypsin from pronase and use thereof |
| 09/15/2004 | EP1455943A2 Device and method for processing biological or chemical substances or substance mixtures thereof |
| 09/15/2004 | EP1455821A2 Parathyroid hormone antibodies and related methods |
| 09/15/2004 | EP1455819A1 Individualized anti-cancer antibodies |
| 09/15/2004 | EP1192263B1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator |
| 09/15/2004 | EP1173547A4 Dwf4 polynucleotides, polypeptides and uses thereof |
| 09/15/2004 | EP1144616B1 Method for producing antibody fragments |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP0942985B1 Broad-spectrum delta-endotoxins |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0833919B1 Type f botulinum toxin and use thereof |
| 09/15/2004 | EP0740553B1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 09/15/2004 | EP0678523B1 Recombinant anti-hiv antibody and preparation thereof |
| 09/15/2004 | EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529757A Fusion Protein for secretion of protein of interest in supernatant of bacterial culture |
| 09/15/2004 | CN1529754A Variable region of monoclonal antibody against HBV S-surface antigene and gene encoding same |
| 09/15/2004 | CN1529753A Disease-associated protein |
| 09/15/2004 | CN1529714A Modified interfron alpha with reduced immunogenicity |
| 09/15/2004 | CN1529712A Process for preparing dipeptide, Peptide synthase to be used therein and process for producing peptide synthase |
| 09/15/2004 | CN1529710A Recombinant protective protein from streptococcus pneumoniae |
| 09/15/2004 | CN1528903A Human alphal 1-thymic peptide gene multicopy directional cloning and high-efficiency expression |
| 09/15/2004 | CN1528791A Specific monoclonal antibody against epitope of clygoprotein coding inactivated feline immunodeficiency virus |
| 09/15/2004 | CN1166772C Process for controlling sialylation of protein produced by mammalian cell culture |
| 09/14/2004 | US6790950 Anti-bacterial vaccine compositions |
| 09/14/2004 | US6790949 Used in the development of a therapeutic agent for neuron or endocrine cell-related diseases; vesicle transport proteins |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790940 For high speed detection |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790658 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790650 Cacao endoproteinases and production of cocoa flavor from same |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790637 Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes |
| 09/14/2004 | US6790630 Glycoproteins; pepsin inhibitors; for detection of heartworm infection in dogs, cats |
| 09/14/2004 | US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment |
| 09/14/2004 | US6790622 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 09/14/2004 | US6790446 Campylobacter vaccine |
| 09/14/2004 | CA2219629C Transgenic animal models for type ii diabetes mellitus |
| 09/14/2004 | CA2130115C Prevention of retinal injury and degeneration by specific factors |
| 09/14/2004 | CA2073113C Conjugates |
| 09/14/2004 | CA2071924C Hepatocellular carcinoma oncogene |
| 09/10/2004 | WO2004077268A2 System and method for dynamic data binding in distributed applications |
| 09/10/2004 | WO2004076666A1 Gasdermin family |
| 09/10/2004 | WO2004076660A1 Virus-adsorbing protein and use thereof |
| 09/10/2004 | WO2004076658A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 09/10/2004 | WO2004076618A2 Genetically modified non-human mammals and cells |
| 09/10/2004 | WO2004076487A1 Antibody and use thereof |
| 09/10/2004 | WO2004076477A1 MICROBIOLOGICAL PRODUCTION METHOD FOR α-L-ASPARTYL-L-PHENYLALANINE |
| 09/10/2004 | WO2004060869A3 Methods and compositions for catalytic dna exchange in a sequence manner |
| 09/10/2004 | WO2004058944A3 Product quality enhancement in mammalian cell culture processes for protein production |
| 09/10/2004 | WO2004058799A3 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 09/10/2004 | WO2004035070A9 Induction of gene expression using a high concentration sugar mixture |
| 09/10/2004 | WO2004030622A3 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 09/10/2004 | WO2004020579A3 Method of humanizing immune system molecules |
| 09/10/2004 | WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 09/10/2004 | WO2003100021A3 Methods and dna constructs for high yield production of polypeptides |
| 09/10/2004 | WO2003094844A3 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms |
| 09/10/2004 | WO2003076643A3 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/10/2004 | WO2003066801A3 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system. |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | WO2002094780A3 Kinases and phosphatases |
| 09/10/2004 | CA2515389A1 Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical compostion, and diagnostic reagent |
| 09/09/2004 | US20040176583 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 09/09/2004 | US20040176582 Expression vector comprising osteocalcin promoter and nucleotide sequence coding bone morphogenic protein for treatment and prevention of osteoporosis |
| 09/09/2004 | US20040176576 Antibodies against cancer |
| 09/09/2004 | US20040176571 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/09/2004 | US20040176568 Nucleic acids encoding modified parathyroid hormone |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040175824 Fc fusion proteins of human erythropoietin with high biological activities |